Pneumococcal conjugate second or third-dose vaccines (PCVc) in New Zealand
New Zealand: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 89.0% in 2025. β² Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in New Zealand, 2008β2025
Source: World Health Organization, Global Health Observatory.
Analysis
New Zealand recorded 89.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
Compared with earlier readings it is up 48.3% on the previous year and down 4.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in New Zealand peaked at 96.0% in 2018 and was at its lowest, 0.0%, in 2008.
That places New Zealand 70th out of 192 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 43.5% | 0.0% | 87.0% | 2 |
| 2010s | 92.6% | 89.0% | 96.0% | 10 |
| 2020s | 82.5% | 60.0% | 95.0% | 6 |
Countries ranked near New Zealand
More health data for New Zealand
- Un projection of annual infant deaths, annual growth rate -2.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4815 % change on previous year (2090)
- Heat deaths vs projected death rates 1,116 (2090)
- Un projection of annual infant deaths 33 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 35,183 (2025)
- Age population, age 25, female, interpolated 33,038 (2025)
- Age population, age 24, male, interpolated 34,878 (2025)
- Age population, age 24, female, interpolated 33,021 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in New Zealand?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in New Zealand was 89.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in New Zealand?
- The highest recorded value was 96.0% in 2018.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in New Zealand?
- The lowest recorded value was 0.0% in 2008.
- How does New Zealand rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- New Zealand ranks 70th out of 192 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in New Zealand?
- Over the last ten years it is down 4.3%. The long-run trend across the full record is rising.
- Where does this New Zealand data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).